Tokyo, Dec. 25 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000059701) titled 'Mortality Impact of REBOA: A Systematic Review and Meta-analysis of Geographic and Patient Population Differences' on Dec. 25.
Study Type:
Others,meta-analysis etc
Primary Sponsor:
Institute - Yokohama City University
Condition:
Condition - Patients with hemorrhagic shock and cardiovascular collapse treated with REBOA
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - The objective of this paper is to determine the impact of REBOA (Resuscitative Endovascular Balloon Occlusion of the Aorta) on mortality in patients with hemorrhagic shock and cardiovascular collapse.
Compare mortality rates between patients who received REBOA and those who did not (non-REBOA).
Analyze whether this impact on mortality differs based on patient populations (trauma vs. non-trauma) or geographic regions.
Basic objectives2 - Efficacy
Eligibility:
Age-lower limit - Not applicable
Age-upper limit - Not applicable
Gender - Male and Female
Key inclusion criteria - Patients with hemorrhagic shock and cardiovascular collapse treated with REBOA.
Key exclusion criteria - No special remarks
Recruitment Status:
Recruitment status - Preinitiation
Date of protocol fixation - 2025 Year 11 Month 08 Day
Anticipated trial start date - 2025 Year 11 Month 11 Day
Last follow-up date - 2025 Year 12 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000068283
Disclaimer: Curated by HT Syndication.
